Equities

AstraZeneca PLC

AZN:LSE

AstraZeneca PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)14,104.00
  • Today's Change124.00 / 0.89%
  • Shares traded3.06m
  • 1 Year change19.67%
  • Beta0.8573
Data delayed at least 20 minutes, as of Feb 06 2026 16:33 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
OPERATIONS
Net income8,6916,8992,501
Depreciation/depletion6,6885,3875,480
Non-Cash items1,4381,206542
Cash taxes paid, supplemental2,7502,3661,623
Cash interest paid, supplemental1,3131,081849
Changes in working capital(4956)(3147)1,285
Total cash from operations11,86110,3459,808
INVESTING
Capital expenditures(4586)(3778)(2571)
Other investing and cash flow items, total(3394)(286)(389)
Total cash from investing(7980)(4064)(2960)
FINANCING
Financing cash flow items(817)(886)(1047)
Total cash dividends paid(4629)(4481)(4364)
Issuance (retirement) of stock, net(43)3329
Issuance (retirement) of debt, net1,493(1233)(1441)
Total cash from financing(3996)(6567)(6823)
NET CHANGE IN CASH
Foreign exchange effects(93)(60)(80)
Net change in cash(208)(346)(55)
Net cash-begin balance/reserved for future use5,6375,9836,038
Net cash-end balance/reserved for future use5,4295,6375,983
SUPPLEMENTAL INCOME
Depreciation, supplemental6,6885,3875,480
Cash interest paid, supplemental1,3131,081849
Cash taxes paid, supplemental2,7502,3661,623
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.